• ABOUT
  • THE GROUP
  • NEWS & MEDIA
  • EVENTS
  • CAREER
  • CONTACT US
  • 0

Abbott RealTime HBV Assay

Abbott RealTime HBV Assay
The Abbott RealTime HBV is an in vitro polymerase chain reaction (PCR) assay for the quantitation of Hepatitis B Virus (HBV) DNA in human plasma or serum from HBV-infected individuals.
Read More
Add to Shortlist

Features & Benefits

  • Enhanced precision – Providing high level of confidence and exceptionalperformance measuring low level viremia
  • Highly sensitive – Accurate monitoring of even low viral loads to enable early detection of changes to patient response status
  • Broad Linear Range – Reduces the need of retesting high viral load sample of all HBV genotypes A - H

Product Details

The Abbott RealTime HBV is an in vitro polymerase chain reaction (PCR) assay for the quantitation of Hepatitis B Virus (HBV) DNA in human plasma or serum from HBV-infected individuals. The Abbott RealTime HBV assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis and for use as an aid in assessing viral response to antiviral treatment as measured by changes in plasma or serum HBV DNA levels.

Abbott RealTime HBV is engineered to quantify all HBV genotypes A-H.

The selection of a highly conserved region within the Surface gene provides for the accurate detection of genotypes A-H. The location of the target region in the N terminal third of the Surface gene ensures that the assay is not impacted by YMDD mutants, HBsAg escape mutants, or drugresistant mutants, as this region is essential for the assembly and secretion of subviral particles, and tolerates only minor structural changes.
Read More